J
J. David Lawson
Researcher at Takeda Pharmaceutical Company
Publications - 29
Citations - 3675
J. David Lawson is an academic researcher from Takeda Pharmaceutical Company. The author has contributed to research in topics: Biology & Chemistry. The author has an hindex of 11, co-authored 20 publications receiving 3386 citations. Previous affiliations of J. David Lawson include Washington State University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Intrinsic Disorder and Protein Function
Journal ArticleDOI
Intrinsic disorder in cell-signaling and cancer-associated proteins.
TL;DR: The data suggest that intrinsically unstructured proteins play key roles in cell-signaling, regulation and cancer, where coupled folding and binding is a common mechanism.
Journal ArticleDOI
Protein flexibility and intrinsic disorder.
Predrag Radivojac,Zoran Obradovic,David K. Smith,Guang Zhu,Slobodan Vucetic,Celeste J. Brown,J. David Lawson,A. Keith Dunker +7 more
TL;DR: The distinctive amino acid biases of high‐B‐factor ordered regions, short disordered regions, and long dis ordered regions indicate that the sequence determinants for these flexibility categories differ from one another, whereas the significantly‐greater‐than‐chance predictability of these categories from sequence suggest that flexible ordered regions and short disorder are, to a significant degree, encoded at the primary structure level.
Journal ArticleDOI
DisProt: a database of protein disorder
Slobodan Vucetic,Zoran Obradovic,Vladimir Vacic,Predrag Radivojac,Kang Peng,Lilia M. Iakoucheva,Marc S. Cortese,J. David Lawson,Celeste J. Brown,Jason G. Sikes,Crystal D. Newton,A. Keith Dunker +11 more
TL;DR: The Database of Protein Disorder (DisProt) is a curated database that provides structure and function information about proteins that lack a fixed three-dimensional structure under putatively native conditions, either in their entirety or in part.
Journal ArticleDOI
Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton’s Tyrosine Kinase
Smith Christopher,Douglas R. Dougan,Mallareddy Komandla,Toufike Kanouni,Beverly M. Knight,J. David Lawson,Mark Sabat,Ewan Taylor,Phong H. Vu,Corey Wyrick +9 more
TL;DR: The discovery and optimization of a series of 4-aminocinnoline-3-carboxamide inhibitors of Bruton's tyrosine kinase are reported, resulting in the identification of a lead compound which reduced paw swelling in a dose- and exposure-dependent fashion in a rat model of collagen-induced arthritis.